What is the address of CABINET ONCOLOGIE DR. FORGET?

The registered office of CABINET ONCOLOGIE DR. FORGET is located at Planchipont 195, 6800 Libramont-Chevigny.

Is CABINET ONCOLOGIE DR. FORGET still active?

Yes. According to the CBE (19 September 2026) CABINET ONCOLOGIE DR. FORGET is active, legal situation “Normale toestand”, started on 6 May 2003.

Is CABINET ONCOLOGIE DR. FORGET registered on Peppol?

Yes, CABINET ONCOLOGIE DR. FORGET is registered on the Peppol network with ID 0208:0480158116.

What is the enterprise number of CABINET ONCOLOGIE DR. FORGET?

The enterprise number of CABINET ONCOLOGIE DR. FORGET is BE0480158116.

When was CABINET ONCOLOGIE DR. FORGET founded?

CABINET ONCOLOGIE DR. FORGET was founded on 6 May 2003.

Who are the directors of CABINET ONCOLOGIE DR. FORGET?

According to the 2025 annual accounts, the directors of CABINET ONCOLOGIE DR. FORGET are: Frédéric FORGET.

Is CABINET ONCOLOGIE DR. FORGET a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 6 May 2003; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did CABINET ONCOLOGIE DR. FORGET make in 2025?

CABINET ONCOLOGIE DR. FORGET posted a profit after taxes of € 212,121 in financial year 2025.

What is the revenue of CABINET ONCOLOGIE DR. FORGET?

As a small company, CABINET ONCOLOGIE DR. FORGET is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 304,827.

CABINET ONCOLOGIE DR. FORGET (Private Limited)

Dossier CABINET ONCOLOGIE DR. FORGET, printed on 19 September 2026 from databakkes.be/en/0480158116/cabinet-oncologie-dr-forget. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

CABINET ONCOLOGIE DR. FORGET from Libramont-Chevigny, company number BE0480158116, closed financial year 2025 with a result of € 212,121 after tax. For that financial year CABINET ONCOLOGIE DR. FORGET recorded a gross margin of € 304,827 and equity of € 1.7 million. Compared with financial year 2024, the result moved from € 218,442 to € 212,121. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 26, 2026.

What it is worth Growing

€ 1.7 million

▲ 20% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 212,121

▼ 3% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 610,945

▲ 59% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 1.4 million.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Taxes

€ 43,056

▲ 97% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 264,492 Gross margin 2022: € 264,492 First fiscal year in the series	€ 313,779 Gross margin 2023: € 313,779 ▲ 19% vs 2022 (€ 264,492) Favourable step	€ 323,471 Gross margin 2024: € 323,471 ▲ 3% vs 2023 (€ 313,779) Favourable step	€ 304,827 Gross margin 2025: € 304,827 ▼ 6% vs 2024 (€ 323,471) Unfavourable step	▼ 6%
Profit after taxes	€ 190,802 Profit after taxes 2022: € 190,802 First fiscal year in the series	€ 206,863 Profit after taxes 2023: € 206,863 ▲ 8% vs 2022 (€ 190,802) Favourable step	€ 218,442 Profit after taxes 2024: € 218,442 ▲ 6% vs 2023 (€ 206,863) Favourable step	€ 212,121 Profit after taxes 2025: € 212,121 ▼ 3% vs 2024 (€ 218,442) Unfavourable step	▼ 3%
Equity	€ 1,314,871 Equity 2022: € 1,314,871 First fiscal year in the series	€ 1,521,734 Equity 2023: € 1,521,734 ▲ 16% vs 2022 (€ 1,314,871) Favourable step	€ 1,389,443 Equity 2024: € 1,389,443 ▼ 9% vs 2023 (€ 1,521,734) Unfavourable step	€ 1,668,426 Equity 2025: € 1,668,426 ▲ 20% vs 2024 (€ 1,389,443) Favourable step	▲ 20%
Total debts	€ 221,978 Total debts 2022: € 221,978 First fiscal year in the series	€ 199,086 Total debts 2023: € 199,086 ▼ 10% vs 2022 (€ 221,978) Favourable step	€ 60,670 Total debts 2024: € 60,670 ▼ 70% vs 2023 (€ 199,086) Favourable step	€ 242,568 Total debts 2025: € 242,568 ▲ 300% vs 2024 (€ 60,670) Unfavourable step	▲ 300%
Cash	€ 545,800 Cash 2022: € 545,800 First fiscal year in the series	€ 694,976 Cash 2023: € 694,976 ▲ 27% vs 2022 (€ 545,800) Favourable step	€ 384,897 Cash 2024: € 384,897 ▼ 45% vs 2023 (€ 694,976) Unfavourable step	€ 610,945 Cash 2025: € 610,945 ▲ 59% vs 2024 (€ 384,897) Favourable step	▲ 59%
Land & buildings	-	-	-	€ 332,407 Land & buildings 2025: € 332,407 First fiscal year in the series
Retained profit	€ 1,292,596 Retained profit 2022: € 1,292,596 First fiscal year in the series	€ 1,499,459 Retained profit 2023: € 1,499,459 ▲ 16% vs 2022 (€ 1,292,596) Favourable step	€ 1,367,168 Retained profit 2024: € 1,367,168 ▼ 9% vs 2023 (€ 1,499,459) Unfavourable step	€ 1,413,153 Retained profit 2025: € 1,413,153 ▲ 3% vs 2024 (€ 1,367,168) Favourable step	▲ 3%
Dividend	€ 190,802 Dividend 2022: € 190,802 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 190,802) Unchanged	€ 350,733 Dividend 2024: € 350,733 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 350,733) Unchanged	▼ 100%
Balance sheet total	€ 1,536,849 Balance sheet total 2022: € 1,536,849 First fiscal year in the series	€ 1,720,820 Balance sheet total 2023: € 1,720,820 ▲ 12% vs 2022 (€ 1,536,849) Unchanged	€ 1,450,113 Balance sheet total 2024: € 1,450,113 ▼ 16% vs 2023 (€ 1,720,820) Unchanged	€ 1,910,994 Balance sheet total 2025: € 1,910,994 ▲ 32% vs 2024 (€ 1,450,113) Unchanged	▲ 32%

Key figures of CABINET ONCOLOGIE DR. FORGET, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to CABINET ONCOLOGIE DR. FORGET?

What happened at CABINET ONCOLOGIE DR. FORGET in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 26, 2026 New annual accounts for financial year 2025: profit of € 212,121 (▼ 3% vs 2024). filed late Source: NBB ↗
May 6, 2003 Start of the company according to the CBE. KBO

In short

From € 190,802 profit in 2022 to € 212,121 profit in 2025.

Paid € 376,805 in corporate taxes since 2022.

Best year ever: 2024, with € 218,442 profit.

Paid out € 541,535 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at CABINET ONCOLOGIE DR. FORGET? We notify you, reason included.

Follow CABINET ONCOLOGIE DR. FORGET

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Frédéric FORGET

CABINET ONCOLOGIE DR. FORGET

Behind CABINET ONCOLOGIE DR. FORGET is Frédéric FORGET.

See the full network in the app

Directors

According to the 2025 annual accounts

Frédéric FORGET

Manager

Establishments

Establishment units

Physical locations of this company

Registered office

Planchipont 195

6800 Libramont-Chevigny

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

VEEL - CONSULT

€ 23,476 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0480.158.116
VAT number: BE 0480.158.116
Registered office: Planchipont 195, 6800 Libramont-Chevigny
Names & denominations: CABINET ONCOLOGIE DR. FORGET
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 6 May 2003
Peppol: Active · Active since 1 Jan 2001

View on CBE Public ↗ Annual accounts (NBB) ↗